Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Genetic Screens02:46

Genetic Screens

5.6K
Genetic screens are tools used to identify genes and mutations responsible for phenotypes of interest. Genetic screens help identify individuals or a group of people at risk of developing  genetic diseases and help them with early intervention, targeted therapy, and reproductive options.
Forward genetic screens
Forward or “classical” genetic screens involve creating random mutations in an organism’s DNA using radiation, mutagens, or insertion of additional bases, which...
5.6K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Elective genomic sequencing for adults in research, clinical and commercial contexts.

medRxiv : the preprint server for health sciences·2026
Same author

Biallelic inactivating variants in the chromatin remodeler DMAP1 cause a syndromic neurodevelopmental disorder.

The Journal of clinical investigation·2026
Same author

Findings from comprehensive genome sequencing in the Canadian population: Results from the GENCOV Study.

Genetics in medicine open·2026
Same author

Whose Role Is It, Anyway? Ensuring Correct Genomic Variant Nomenclature in Published Literature.

Clinical chemistry·2026
Same author

Language models reveal evidence gaps in variants of uncertain significance.

medRxiv : the preprint server for health sciences·2026
Same author

Disruption of the human cystin-1 myristoyl-electrostatic switch causes polycystic kidney disease that phenocopies autosomal recessive polycystic kidney disease.

Kidney international·2026
Same journal

Accuracy of Cytology Diagnosis for Well Differentiated Neuroendocrine Tumors: Assessment by the College of American Pathologists Non-Gynecologic Slide Program.

Archives of pathology & laboratory medicine·2026
Same journal

Serum Immunofixation Electrophoresis Guidance Conflict: A Call to Harmonize.

Archives of pathology & laboratory medicine·2026
Same journal

In Reply.

Archives of pathology & laboratory medicine·2026
Same journal

Journal Club and Artificial Intelligence.

Archives of pathology & laboratory medicine·2026
Same journal

In Reply.

Archives of pathology & laboratory medicine·2026
Same journal

Using R Statistical Programming to Evaluate the Impact of the Lower Anogenital Squamous Terminology Recommendations on Cervical Biopsy Reporting at a Tertiary Care Academic Center.

Archives of pathology & laboratory medicine·2026
See all related articles

Related Experiment Video

Updated: Jan 15, 2026

A Strategy to Identify de Novo Mutations in Common Disorders such as Autism and Schizophrenia
05:51

A Strategy to Identify de Novo Mutations in Common Disorders such as Autism and Schizophrenia

Published on: June 15, 2011

26.3K

Phenotype-Driven In Silico Proficiency Testing Represents a Viable Approach for Undiagnosed Disorders by Exome

Ryan J Schmidt, Birgit Funke, Ann King

    Archives of Pathology & Laboratory Medicine
    |January 13, 2026
    PubMed
    Summary
    This summary is machine-generated.

    In silico mutagenesis offers a promising method for exome sequencing proficiency testing, especially for rare variants. This approach effectively assesses both analytical and interpretative lab performance in identifying genetic disorders.

    More Related Videos

    In Vivo Modeling of the Morbid Human Genome using Danio rerio
    12:31

    In Vivo Modeling of the Morbid Human Genome using Danio rerio

    Published on: August 24, 2013

    21.2K
    Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease
    09:34

    Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease

    Published on: April 4, 2018

    34.6K

    Related Experiment Videos

    Last Updated: Jan 15, 2026

    A Strategy to Identify de Novo Mutations in Common Disorders such as Autism and Schizophrenia
    05:51

    A Strategy to Identify de Novo Mutations in Common Disorders such as Autism and Schizophrenia

    Published on: June 15, 2011

    26.3K
    In Vivo Modeling of the Morbid Human Genome using Danio rerio
    12:31

    In Vivo Modeling of the Morbid Human Genome using Danio rerio

    Published on: August 24, 2013

    21.2K
    Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease
    09:34

    Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease

    Published on: April 4, 2018

    34.6K

    Area of Science:

    • Genomics
    • Bioinformatics
    • Medical Diagnostics

    Background:

    • In silico mutagenesis can introduce variants into next-generation sequencing data.
    • This method is promising for proficiency testing, enabling the modeling of rare or novel variants absent in current materials.

    Purpose of the Study:

    • To evaluate in silico mutagenesis as a proficiency testing methodology for exome sequencing in undiagnosed disorders.

    Main Methods:

    • Laboratories performed exome sequencing on reference samples.
    • Raw sequence data underwent in silico mutagenesis to add specific variants.
    • Mutagenized files were processed through bioinformatic pipelines for variant interpretation.

    Main Results:

    • Seven educational proficiency testing challenges were conducted from 2018-2021 with an average of 47 participating laboratories.
    • Participating laboratories returned an average of 94.3% of intended response variants.
    • The percentage of laboratories correctly identifying all intended variants ranged from 70.0% to 96.7%.

    Conclusions:

    • In silico mutagenesis is a suitable approach for proficiency testing in exome sequencing.
    • This method allows for graded, intended response-based testing.
    • It enables laboratories to assess both analytical and interpretative aspects of genetic testing.